SYNOVIAL PROTEIN-KINASE-C AND ITS APPARENT INSENSITIVITY TO INTERLEUKIN-1

被引:5
|
作者
HULKOWER, KI
SAGIEISENBERG, R
TRAUB, LM
GEORGESCU, HI
EVANS, CH
机构
[1] UNIV PITTSBURGH,SCH MED,FERGUSON LAB ORTHOPAED RES,986 SCAIFE HALL,PITTSBURGH,PA 15261
[2] WEIZMANN INST SCI,DEPT CHEM IMMUNOL,IL-76100 REHOVOT,ISRAEL
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1992年 / 209卷 / 01期
关键词
D O I
10.1111/j.1432-1033.1992.tb17263.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lapine synovial fibroblasts produce prostaglandin E2 (PGE2) and neutral metalloproteinases in response to phorbol 12-myristate 13-acetate (PMA), human recombinant interleukin-I (hrIL-1) and, in an autocrine fashion, in response to partially purified preparations of their own cytokines known as cell-activating factors (CAF). Here we have examined the possible role of protein kinase C (PKC) in these responses. Whereas the 80-kDa substrate for PKC could not be detected in synovial fibroblasts, these cells contained a 35-kDa protein which fulfilled the criteria for qualifying as a specific substrate of PKC. Translocation assays based upon phosphorylation of the 35-kDa protein and Western blotting techniques allowed the movement of PKC from the cytosolic to the particulate fraction in response to PMA and CAF to be detected but not in response to 4alpha-PMA or hrIL-1. Inhibitors of PKC suppressed synovial activation by PMA, partially blocked activation by CAF but had no effect on activation by hrIL-1. There thus appear to be PKC-dependent and PKC-independent routes to synovial cell activation. Our data suggest that IL-1 uses the latter, while CAF contains cytokines which utilize both routes.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 50 条
  • [41] EXPRESSION OF INTERLEUKIN-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST BY HUMAN RHEUMATOID SYNOVIAL TISSUE MACROPHAGES
    KOCH, AE
    KUNKEL, SL
    CHENSUE, SW
    HAINES, GK
    STRIETER, RM
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 65 (01): : 23 - 29
  • [42] Interleukin-1, interleukin-1 receptor antagonist and macrophage populations in rheumatoid arthritis synovial membrane
    Cauli, A
    Yanni, G
    Panayi, GS
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (09): : 935 - 940
  • [43] ACTIVATION OF THE RAF-1 PROTEIN-KINASE BY PROTEIN-KINASE-C PHOSPHORYLATION
    STABEL, S
    SOZERI, O
    LIYANAGE, M
    MARQUARDT, B
    MARK, GE
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 276 - 276
  • [44] INHIBITION OF SARCOLEMMAL PROTEIN PHOSPHATASE-1 BY PROTEIN-KINASE-C
    DUAN, J
    WILSON, G
    SCHAFFER, SW
    FASEB JOURNAL, 1991, 5 (04): : A831 - A831
  • [45] MYRISTOYLATION OF PROTEIN AT A DISTINCT POSITION ALLOWS ITS PHOSPHORYLATION BY PROTEIN-KINASE-C
    UTSUMI, T
    TOKUNAGA, T
    HORII, J
    EDASHIGE, K
    UTSUMI, K
    KOGA, D
    IDE, A
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 313 (02) : 337 - 345
  • [46] INTERLEUKIN-1 AND INTERLEUKIN-2 AND INTERLEUKIN INHIBITORS IN SYNOVIAL-FLUID
    HOPKINS, SJ
    VANDERZEIL, P
    HUMPHRIES, M
    JAYSON, MIV
    BRITISH JOURNAL OF RHEUMATOLOGY, 1986, 25 : 84 - 84
  • [47] Identification of the intracellular portion responsible for interleukin-1 activation of protein kinase A
    Joseph, A
    Jueppner, H
    Gwosdow, A
    FASEB JOURNAL, 1996, 10 (03): : 2437 - 2437
  • [48] INTERLEUKIN-1 AND PROTEIN-KINASE-C ACTIVATOR ARE DISSIMILAR IN THEIR EFFECTS ON II-2 RECEPTOR EXPRESSION AND II-2 SECRETION BY LYMPHOCYTES-T
    TRUNEH, A
    SIMON, P
    SCHMITTVERHULST, AM
    CELLULAR IMMUNOLOGY, 1986, 103 (02) : 365 - 374
  • [49] Requirement for protein kinase R in interleukin-1α-stimulated effects in cartilage
    Christine, L. Tam
    Hofbauer, Maria
    Towle, Christine A.
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (11) : 1636 - 1641
  • [50] UP-REGULATION OF IFN-GAMMA RECEPTORS BY TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 - MODULATION BY CA2+ AND PROTEIN-KINASE-C
    RAITANO, AB
    KORC, M
    CLINICAL RESEARCH, 1991, 39 (01): : A68 - A68